What’s new?

US based biotechnology company appoints BRC

by | Nov 19, 2017

A global US corporation, involved in the development and manufacture of therapies to combat serious neurological, autoimmune and rare diseases, approached BRC with a view to exploring the benefits of a best market practice review of its UK based international treasury and cash management operation. The review would focus on the existing Treasury policy, procedures and processes.

A site visit was undertaken during which interviews were held with key Treasury staff, together with process demonstrations, to get a first-hand understanding of the existing treasury and cash management operation. The results of the review were compared with Treasury operations in other multi-national corporations with which BRC has been involved, in order to highlight where beneficial improvements could be implemented.

The review concluded with a report on findings and recommendations, and the subsequent delivery by BRC of a comprehensive Treasury Policy Guide and documented operating procedures.